186 related articles for article (PubMed ID: 37899146)
1. Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands.
Schwartz ER; Rensen N; Steur LMH; Gemke R; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; Kaspers GJL; Van Litsenburg RRL
BMJ Open; 2023 Oct; 13(10):e070804. PubMed ID: 37899146
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of quality of life in children treated in UKALL 2003 for acute lymphoblastic leukaemia: A cohort study.
Eiser C; Stride CB; Vora A; Goulden N; Mitchell C; Buck G; Adams M; Jenney MEM;
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28475268
[TBL] [Abstract][Full Text] [Related]
3. Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN
BMC Cancer; 2022 Sep; 22(1):985. PubMed ID: 36109702
[TBL] [Abstract][Full Text] [Related]
4. Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study.
de Vries MA; van Litsenburg RR; Huisman J; Grootenhuis MA; Versluys AB; Kaspers GJ; Gemke RJ
Health Qual Life Outcomes; 2008 Nov; 6():103. PubMed ID: 19036151
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in children and adolescents after treatment for acute lymphoblastic leukemia according to the NOPHO ALL2008 protocol.
Mogensen N; Kreicbergs U; Albertsen BK; Lähteenmäki PM; Heyman M; Harila A
Pediatr Blood Cancer; 2024 Jul; 71(7):e31018. PubMed ID: 38644601
[TBL] [Abstract][Full Text] [Related]
6. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
Mitchell HR; Lu X; Myers RM; Sung L; Balsamo LM; Carroll WL; Raetz E; Loh ML; Mattano LA; Winick NJ; Devidas M; Hunger SP; Maloney K; Kadan-Lottick NS
Int J Cancer; 2016 Jan; 138(2):332-9. PubMed ID: 26235006
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial screening at paediatric BEEC clinics: a pilot evaluation study.
Hurrell RA; Fullwood C; Keys J; Dickson AP; Fishwick J; Whitnall B; Cervellione RM
J Pediatr Urol; 2015 Apr; 11(2):79.e1-6. PubMed ID: 25812470
[TBL] [Abstract][Full Text] [Related]
8. Comparison of child and family reports of health-related quality of life in pediatric acute lymphoblastic leukemia patients after induction therapy.
Nakajima S; Sato I; Soejima T; Koh K; Kato M; Okamoto Y; Imamura T; Maeda M; Ishida Y; Manabe A; Kamibeppu K
BMC Pediatr; 2020 Aug; 20(1):390. PubMed ID: 32814552
[TBL] [Abstract][Full Text] [Related]
9. Determinants of quality of life during induction therapy in pediatric acute lymphoblastic leukemia.
van Litsenburg RR; Huisman J; Pieters R; Verhaak C; Kaspers GJ; Gemke RJ
Support Care Cancer; 2014 Dec; 22(12):3235-42. PubMed ID: 25011520
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
Zheng DJ; Lu X; Schore RJ; Balsamo L; Devidas M; Winick NJ; Raetz EA; Loh ML; Carroll WL; Sung L; Hunger SP; Angiolillo AL; Kadan-Lottick NS
Cancer; 2018 Feb; 124(3):571-579. PubMed ID: 29112230
[TBL] [Abstract][Full Text] [Related]
11. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
[TBL] [Abstract][Full Text] [Related]
14. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia.
Meeske K; Katz ER; Palmer SN; Burwinkle T; Varni JW
Cancer; 2004 Nov; 101(9):2116-25. PubMed ID: 15389475
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in adults treated for paediatric acute lymphoblastic leukaemia: a cross-sectional and longitudinal cohort study.
Aili K; Arvidsson S; Olsson M; Jarfelt M; Nygren J
BMJ Open; 2022 Jan; 12(1):e048325. PubMed ID: 34996782
[TBL] [Abstract][Full Text] [Related]
16. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
[TBL] [Abstract][Full Text] [Related]
17. Cognitive functioning, patient health communication, and worry mediate pain predictive effects on health-related quality of life in youth with sickle cell disease.
Varni JW; Panepinto JA
Pediatr Blood Cancer; 2020 Nov; 67(11):e28680. PubMed ID: 32860648
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia.
Sitaresmi MN; Mostert S; Gundy CM; Sutaryo ; Veerman AJ
Health Qual Life Outcomes; 2008 Nov; 6():96. PubMed ID: 18992169
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in paediatric patients up to five years post-treatment completion for acute lymphoblastic leukaemia: a systematic review.
Garas A; McLean LA; De Luca CR; Downie P; McCarthy MC
Support Care Cancer; 2019 Nov; 27(11):4341-4351. PubMed ID: 30900055
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
